Skip to main content
Top

Cancer Causes & Control

Issue 1/2002

Content (11 Articles)

Editorial Introduction

Prostate cancer screening practices and cancer control research (United States)

David Schottenfeld, Graham A. Colditz

Birth characteristics, maternal reproductive history, hormone use during pregnancy, and risk of childhood acute lymphocytic leukemia by immunophenotype (United States)

Xiao Ou Shu, Dehui Han, Richard K. Severson, Zhi Chen, Joseph P. Neglia, Gregory H. Reaman, Jonathan D. Buckley, Leslie L. Robison

The importance of smoking and medical history for development of small bowel carcinoid tumor: a European population-based case–control study

Linda Kaerlev, Peter Stubbe Teglbjaerg, Svend Sabroe, Henrik A. Kolstad, Wolfgang Ahrens, Mikael Eriksson, Pascal Guénel, Giuseppe Gorini, Lennart Hardell, Diane Cyr, Paola Zambon, Andreas Stang, Jorn Olsen

Risk of epithelial ovarian cancer in relation to use of antidepressants, benzodiazepines, and other centrally acting medications

Sascha Dublin, Mary Anne Rossing, Susan R. Heckbert, Barbara A. Goff, Noel S. Weiss

Childbearing and the risk of leukemia in Sweden

Karin Ekström, Joanne Wuu, Chung-Cheng Hsieh, Bengt Glimelius, Mats Lambe

Body mass index, tobacco chewing, alcohol drinking and the risk of oral submucous fibrosis in Kerala, India

Mia Hashibe, Rengaswamy Sankaranarayanan, Gigi Thomas, Binu Kuruvilla, Babu Mathew, Thara Somanathan, Donald Maxwell Parkin, Zuo-Feng Zhang

Stage-specific incidence of breast cancer before the beginning of organized screening programs in Italy

Eva Buiatti, Alessandro Barchielli, Simone Bartolacci, Lauro Bucchi, Vincenzo De Lisi, Massimo Federico, Stefano Ferretti, Eugenio Paci, Marcello Vettorazzi, Roberto Zanetti

Sociodemographic predictors of non-attendance at invitational mammography screening – a population-based register study (Sweden)

Magdalena Lagerlund, Annette E. Maxwell, Roshan Bastani, Erik Thurfjell, Anders Ekbom, Mats Lambe

A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands)

Maurice P.A. Zeegers, R. Alexandra Goldbohm, Piet A. van den Brandt

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine